LivaNova PLC - Ordinary Shares (LIVN) earnings
LIVN earnings moved a median of +0.90% by the close. Quarterly and annual LIVN reports and results, each read against the price at its own news timestamp. Back to the LIVN overview →
31 measured LIVN earnings events.
Where these LIVN earnings landedvs 31 measured LIVN earnings reactions
| Middle 50% of LIVN earnings reactions | -1.14% to +1.59% |
|---|---|
| Median reaction (to close) | +0.90% |
| Measured reactions | 31 |
Point-in-time · zero look-ahead
Half of the 31 LIVN earnings events with a measured close landed between -1.14% and +1.59%; 61% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| LivaNova to Announce Third-Quarter 2026 Results | Press release | +0.00% | -1.57% | |
| Form 10-Q LivaNova PLC For: Jun 30 | SEC filing · Form 10-Q | +0.40% | +2.27% | |
| LivaNova Reports Second-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance | Press release | +0.16% | -2.17% | |
| LivaNova to Announce Second-Quarter 2026 Results | Press release | +1.18% | +1.61% | |
| Form 10-Q LivaNova PLC For: Mar 31 | SEC filing · Form 10-Q | -0.07% | +0.90% | |
| LivaNova Reports First-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance | Press release | +6.48% | +8.62% | |
| LivaNova to Announce First-Quarter 2026 Results | Press release | -0.15% | +0.10% | |
| Form 10-K LivaNova PLC For: Dec 31 | SEC filing · Form 10-K | -0.14% | +0.77% | |
| Form 10-Q LivaNova PLC For: Sep 30 | SEC filing · Form 10-Q | -0.13% | -2.47% | |
| LivaNova Reports Third-Quarter 2025 Results; Raises 2025 Guidance | Press release | +2.13% | -2.36% | |
| LivaNova to Announce Third-Quarter 2025 Results | Press release | -0.30% | +1.50% | |
| Form 10-Q LivaNova PLC For: Jun 30 | SEC filing · Form 10-Q | -0.11% | +2.73% | |
| LivaNova Reports Second-Quarter 2025 Results; Raises 2025 Guidance | Press release | -0.11% | +2.73% | |
| LivaNova to Announce Second-Quarter 2025 Results | Press release | +0.76% | +1.09% | |
| Form 10-Q LivaNova PLC For: Mar 31 | SEC filing · Form 10-Q | +0.70% | -0.23% | |
| LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance | Press release | +7.24% | +10.35% | |
| LivaNova to Announce First-Quarter 2025 Results | Press release | -0.01% | -0.40% | |
| Form 10-K LivaNova PLC For: Dec 31 | SEC filing · Form 10-K | -0.02% | +1.07% | |
| Form 10-Q LivaNova PLC For: Sep 30 | SEC filing · Form 10-Q | -0.44% | +1.06% | |
| LivaNova Reports Third-Quarter 2024 Results | Press release | +0.79% | -7.04% | |
| LivaNova to Announce Third-Quarter 2024 Results | Press release | +0.12% | +0.43% | |
| Form 10-Q LivaNova PLC For: Jun 30 | SEC filing · Form 10-Q | +0.29% | -1.36% | |
| LivaNova Reports Second-Quarter 2024 Results | Press release | -3.32% | -7.26% | |
| LivaNova to Announce Second-Quarter 2024 Results | Press release | -0.08% | +0.93% | |
| Form 10-Q LivaNova PLC For: Mar 31 | SEC filing · Form 10-Q | -0.08% | +1.02% | |
| LivaNova Reports First-Quarter 2024 Results | Press release | -0.80% | +4.54% | |
| Bigtincan Holdings (ASX:BTH) - Bigtincan's AI Investments Pay Off, Achieves Record Q3 Results with Surge in EBITDA and Free Cash Flow | Press release | +0.63% | -2.33% | |
| LivaNova to Announce First-Quarter 2024 Results | Press release | -0.78% | -0.92% | |
| Form 10-K LivaNova PLC For: Dec 31 | SEC filing · Form 10-K | +0.04% | -0.38% | |
| Form 10-Q LivaNova PLC For: Sep 30 | SEC filing · Form 10-Q | +0.61% | +1.56% | |
| LivaNova Reports Third-Quarter 2023 Results | Press release | +6.52% | +6.86% |
Keep exploring
More LIVN: analyst actions → · SEC filings → · LIVN overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Delcath Systems, Inc. (DCTH) | 275 | -0.27% | 42% |
| Evolus, Inc. (EOLS) | 275 | +0.08% | 51% |
| Puma Biotechnology Inc (PBYI) | 274 | +0.44% | 55% |
| PRANA BIOTECH (PRAN) | 274 | 0.00% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.